ReviewFrontiers in immunology2024

Naturally selected CD7-directed CAR-T bridging allo-HSCT in refractory acute myeloid leukemia: a case report and review.

Xuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.